Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene ΔF508 mutation

Diabetes Care

Volumn 30, Issue 5, 2007, Pages 1187-1192

  Preumont, Vanessa ^a   Hermans, Michel P ^a   Lebecque, Patrick ^a   Buysschaert, Martin ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; PANCREATIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ADULT; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PANCREAS INSUFFICIENCY;

ADOLESCENT; ADULT; AGE OF ONSET; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DIABETES MELLITUS; FEMALE; GENOTYPE; GLUCOSE; GLUCOSE INTOLERANCE; HETEROZYGOTE DETECTION; HOMEOSTASIS; HOMOZYGOTE; HUMANS; INSULIN; MALE; MUTATION; NUTRITIONAL STATUS; PHENOTYPE; PREDIABETIC STATE;

EID: 34247576238     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1915     Document Type: Article

References (40)

1. Mackie ADR, Thornton SJ, Edenborough FP: Cystic fibrosis-related diabetes. Diabet Med 20:425-436, 2003
2. Costa M, Potvin S, Berthiaume Y, Gauthier L, Jeanneret A, Lavoie A, Levesque R, Chiasson JL, Rabasa-Lhoret R: Diabetes : a major co-morbidity in cystic fibrosis. Diabetes Metab 31:221-232, 2005
3. Buysschaert M, Hermans MP, Preumont V: Le diabète dans la mucoviscidose: un ètat des lieux en 2006. In Mises au Point Cliniques d'Endocrinologie, Nutrition, et Métabolisme: Les Editions de Médecine Pratique. Guéritée N, Leclère J, Eds., Paris, Les Editions de Médecine Pratique, 2006, p. 241-254
4. Rowe SM, Miller S, Sorscher EJ: Mechanisms of disease: cystic fibrosis. N Engl J Med 352:1992-2001, 2005
5. Kerem E, Corey M, Kerem B, Rommens J, Markiewicz D, Levison H, Tsui LC, Durie P: The relation between genotype and phenotype in cystic fibrosis: analysis of the most common mutation (ΔF508). N Engl J Med 323:1517-1522, 1990
6. Ratjen F, Doring G: Cystic fibrosis. Lancet 361:681-689, 2003
7. Hardin DS, Moran A: Diabetes mellitus in cystic fibrosis. Endocrinol Metab Clin North Am 28:787-800, 1999
8. Moran A, Hardin D, Rodman D, Allen HF, Beall RJ, Borowitz D, Brunzell C, Campbell III PW, Chesrown SE, Duchow C, Fink RJ, Fitzsimmons SC, Hamilton N, Hirsch I, Howenstine MS, Klein DJ, Madhun Z, Pencharz PB, Quittner AL, Robbins MK, Schindler T, Schissel K, Schwarzenberg SJ, Stallings VA, Tullis DE, Zipf WB, et al.: Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res and Clin Pract 45:61-73, 1999
9. The cystic fibrosis genotype-phenotype consortium: correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 329:1308-1313, 1993
10. Hamdi I, Payne SJ, Barton DE, McMahon R, Green M, Shneerson JM, Hales CN: Genotype analysis in cystic fibrosis in relation to the occurrence of diabetes mellitus. Clin Genet 43:186-189, 1993
11. Rosenecker J, Eichler I, Kühn L, Harms HK, von der Hardt H: Genetic determination of diabetes mellitus in patients with cystic fibrosis: Multicenter Cystic Fibrosis Study Group. J Pediatr 127:441-443, 1995
12. Cucinotta D, De Luca F, Scoglio R, Lombardo F, Sferlazzas C, DiBenedetto A, Magazzu G, Raimondo G, Arrigo T: Factors affecting diabetes mellitus onset in cystic fibrosis: evidence from a 10-year follow-up study. Acta Pediatr 88:389-393, 1999
13. Lanng S, Thorsteinsson B, Erichsen G, Nerup J, Koch C: Glucose tolerance in cystic fibrosis. Arch Dis Child 66:612-616, 1991
14. Cotellessa M, Minicucci L, Diana MC, Diana M, Prigione F, Di Febbraro L, Gagliardini R, Manca A, Battistini F, Taccetti G, Magazzu G, Padoan R, Pizzamiglio G, Raia V, Iapicino V, Cardella F, Grinzich G, Lucidi V, Tuccio V, Bignamini E, Salvatore D, Lorini R: Phenotype/genotype correlation and cystic fibrosis related diabetes mellitus (Italian Multicenter Study). J Pediatr Endocrinol Metab 13:1087-1093, 2000
15. Braun J, Arnemann J, Lohrey M, Donner H, Siegmund T, Usadel K, Badenhoop K: No association between the delta F508 cystic fibrosis mutation and type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 107:568-569, 1999
16. Hardin D, Leblanc A, Marshall G, Seilheimer D: Mechanisms of insulin resistance in cystic fibrosis. Am J Physiol Endorinol Metab 281:E1022-E1028, 2001
17. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
18. Hermans MP, Levy J, Morris RJ, Turner RC: Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 42:678-687, 1999
19. Hermans MP, Levy J, Morris RJ, Turner RC: Comparison of tests of β-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 48:1779-1786, 1999
20. Kahn SE, Prigeon RL, Mc Culloch DK, Boyko EJ, Berman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte D Jr: Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function. Diabetes 42:1663-1672, 1993
21. Guerrero-Romero F, Rodriguez-Moran M: Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus. Eur J Clin Invest 36:796-802, 2006
22. Armitage P, Berry G: Statistical Methods in Medical Research. 3rd ed. Oxford, U.K., Blackwell Scientific Publications, 1994, p. 112-113 and 207-214
23. Lanng S, Hansen A, Thorsteinsson B, Nerup J, Koch C: Glucose tolerance in patients with cystic fibrosis: five-year prospective study. Br Med 311:655-659, 1995
24. Marshall BC, Butler SM, Stoddard M, Moran AM, Liou TG, Morgan WJ: Epidemiology of cystic fibrosis-related diabetes. J Pediatr 146:681-687, 2005
25. De Luca F, Arrigo T, Conti Nibali S, Sferlazzas C, Gigante A, Di Cesare E, Cucinotta D: Insulin secretion, glycosylated haemoglobin and islet cell antibodies in cystic fibrosis children and adolescents with different degrees of glucose tolerance. Horm Metab Res 23:495-498, 1991
26. Derbel S, Doumaguet C, Hubert D, Mosnier-Pudar H, Grabar S, Chelly J, Bienvenu TH: Calpain 10 and development of diabetes mellitus in cystic fibrosis. J Cystic Fibrosis 5:47-51, 2006
27. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace RP, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, Darrah RJ, Dorfman R, Sandford AJ, Corey M, Zielenski J, Durie P, Goddard K, Yankaskas JR, Wright FA, Knowles MR; Gene Modifier Study Group: Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 353:1443-1453, 2005
28. Tofé S, Moreno JC, Máiz L, Alonso M, Escobar H, Barrio R: Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis. Eur J Endocrinol 152:241-247, 2005
29. Ahmad T, Nelson R, Taylor R: Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis. Metabolism 43:163-167, 1994
30. Moran A, Pyzdrowski KL, Weinreb J, Kahn BB, Smith SA, Adams KS, Seaquist ER: Insulin sensitivity in cystic fibrosis. Diabetes 43:1020-1026, 1994
31. Holl RW, Heinze E, Wolf A, Rank M, Teller WM: Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis. Eur J Pediatr 154:356-361, 1995
32. Hardin D, Leblanc A, Lukenbaugh S, Seilheimer D: Insulin resistance is associated with decreased clinical status in cystic fibrosis. J Pediatr 130:948-956, 1997
33. Austin A, Kalhan S, Orenstein D, Nixon P, Arslanian S: Roles of insulin resistance and β-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis. J Clin Endocrinol Metab 79:80-85, 1994
34. Hardin DS, LeBlanc A, Para L, Seilheimer DK: Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis. Diabetes 48:1082-1087, 1999
35. Lombardo F, De Luca F, Rosano M, Sferlazzas C, Lucanto C, Arrigo T, Messina MF, Crisafulli G, Wasniewska M, Valenzise M, Cucinotta D: Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia. Eur J Endocrinol 149:53-59, 2003
36. Lanng S, Thorsteinsson B, Roder M, Nerup J, Koch C: Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clin Endocrinol 41:217-223, 1994
37. Yung B, Noormohamed FH, Kemp M, Hooper J, Lant AF, Hodson ME: Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and β-cell dysfunction. Diabet Med 19:221-226, 2002
38. Couce M, O'Brien TD, Moran A, Roche PC, Butler PC: Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis. J Clin Endocrinol Metab 81:1267-1272, 1996
39. Rolon M, Benali K, Munck A, Navarro J, Clement A, Tubiana-Rufi N, Czernichon P, Polak M: Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 90:860-867, 2001
40. Lanng S, Thorsteinsson B, Nerup J, Koch C: Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr 83:849-853, 1994